Alexandria Real Estate Equities (ARE) Shares Drop

Alexandria Real Estate Equities marked a -4.35% change today, compared to -0.12368453% for the S&P 500. Is it a good value at today's price of $143.26? Only an in-depth analysis can answer that question, but here are some facts that can give you an idea:

  • Alexandria Real Estate Equities, Inc. is an American real estate investment trust that invests in office buildings and laboratories leased to tenants in the life science and technology industries.

  • Alexandria Real Estate Equities belongs to the Real Estate sector, which has an average price to earnings (P/E) ratio of 24.81 and an average price to book (P/B) of 2.24

  • The company's P/B ratio is 1.425

  • Alexandria Real Estate Equities has a trailing 12 month Price to Earnings (P/E) ratio of 44.91 based on its trailing 12 month price to earnings (EPS) of $3.19 per share

  • Its forward P/E ratio is 37.9, based on its forward earnings per share (EPS) of $3.78

  • ARE has a Price to Earnings Growth (PEG) ratio of 844.2, which shows the company is overvalued when we factor growth into the price to earnings calculus.

  • Over the last four years, Alexandria Real Estate Equities has averaged free cash flows of $-3,746,596,400.00, which on average grew -39.15%

  • ARE's gross profit margins have averaged 62.78 % over the last four years and during this time they had a growth rate of 6.16 % and a coefficient of variability of 14 %.

  • Alexandria Real Estate Equities has moved -17.77% over the last year compared to -9.49% for the S&P 500 -- a difference of -8.28%

  • ARE has an average analyst rating of buy and is -20.1% away from its mean target price of $179.3 per share

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.